We provide you with 20 years of free, institutional-grade data for TNXP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TNXP. Explore the full financial landscape of TNXP stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-03-18 | 1430306 | TNXP | 10-K | Url |
| 2024-11-12 | 1430306 | TNXP | 10-Q | Url |
| 2024-08-16 | 1430306 | TNXP | 10-Q | Url |
| 2024-05-13 | 1430306 | TNXP | 10-Q | Url |
| 2024-04-01 | 1430306 | TNXP | 10-K | Url |
| 2023-11-09 | 1430306 | TNXP | 10-Q | Url |
| 2023-08-10 | 1430306 | TNXP | 10-Q | Url |
| 2023-05-08 | 1430306 | TNXP | 10-Q | Url |
| 2023-03-13 | 1430306 | TNXP | 10-K | Url |
| 2022-11-07 | 1430306 | TNXP | 10-Q | Url |
| 2022-08-08 | 1430306 | TNXP | 10-Q | Url |
| 2022-05-09 | 1430306 | TNXP | 10-Q | Url |
| 2022-03-14 | 1430306 | TNXP | 10-K | Url |
| 2021-11-08 | 1430306 | TNXP | 10-Q | Url |
| 2021-08-09 | 1430306 | TNXP | 10-Q | Url |
| 2021-05-10 | 1430306 | TNXP | 10-Q | Url |
| 2021-03-15 | 1430306 | TNXP | 10-K | Url |
| 2020-11-09 | 1430306 | TNXP | 10-Q | Url |
| 2020-08-10 | 1430306 | TNXP | 10-Q | Url |
| 2020-05-12 | 1430306 | TNXP | 10-Q | Url |
| 2020-03-24 | 1430306 | TNXP | 10-K | Url |
| 2020-01-21 | 1430306 | TNXP | S-1 | Url |
| 2019-11-08 | 1430306 | TNXP | 10-Q | Url |
| 2019-10-18 | 1430306 | TNXP | S-1 | Url |
| 2019-08-23 | 1430306 | TNXP | S-1 | Url |
| 2019-08-12 | 1430306 | TNXP | 10-Q | Url |
| 2019-06-19 | 1430306 | TNXP | S-1 | Url |
| 2019-05-13 | 1430306 | TNXP | 10-Q | Url |
| 2019-03-18 | 1430306 | TNXP | 10-K | Url |
| 2018-11-09 | 1430306 | TNXP | 10-Q | Url |
| 2018-10-24 | 1430306 | TNXP | S-1 | Url |
| 2018-09-07 | 1430306 | TNXP | S-1 | Url |
| 2018-08-13 | 1430306 | TNXP | 10-Q | Url |
| 2018-05-11 | 1430306 | TNXP | 10-Q | Url |
| 2018-03-09 | 1430306 | TNXP | 10-K | Url |
| 2017-11-06 | 1430306 | TNXP | 10-Q | Url |
| 2017-09-29 | 1430306 | TNXP | S-1 | Url |
| 2017-08-11 | 1430306 | TNXP | 10-Q | Url |
| 2017-05-12 | 1430306 | TNXP | 10-Q | Url |
| 2017-04-13 | 1430306 | TNXP | 10-K | Url |
| 2016-11-10 | 1430306 | TNXP | 10-Q | Url |
| 2016-08-05 | 1430306 | TNXP | 10-Q | Url |
| 2016-05-06 | 1430306 | TNXP | 10-Q | Url |
| 2016-03-03 | 1430306 | TNXP | 10-K | Url |
| 2015-11-06 | 1430306 | TNXP | 10-Q | Url |
| 2015-08-07 | 1430306 | TNXP | 10-Q | Url |
| 2015-05-08 | 1430306 | TNXP | 10-Q | Url |
| 2015-02-27 | 1430306 | TNXP | 10-K | Url |
| 2014-11-07 | 1430306 | TNXP | 10-Q | Url |
| 2014-08-08 | 1430306 | TNXP | 10-Q | Url |
| 2014-05-13 | 1430306 | TNXP | 10-Q | Url |
| 2014-03-28 | 1430306 | TNXP | 10-K | Url |
| 2013-11-13 | 1430306 | TNXP | 10-Q | Url |
| 2013-08-14 | 1430306 | TNXP | 10-Q | Url |
| 2013-05-10 | 1430306 | TNXP | S-1 | Url |
| 2013-05-07 | 1430306 | TNXP | 10-Q | Url |
| 2013-03-11 | 1430306 | TNXP | 10-K | Url |
| 2013-01-25 | 1430306 | TNXP | S-1 | Url |
| 2012-11-14 | 1430306 | TNXP | 10-Q | Url |
| 2012-08-13 | 1430306 | TNXP | 10-Q | Url |
| 2012-05-15 | 1430306 | TNXP | 10-Q | Url |
| 2012-04-26 | 1430306 | TNXP | S-1 | Url |
| 2012-03-30 | 1430306 | TNXP | 10-K | Url |
| 2011-10-07 | 1430306 | TNXP | 10-Q | Url |
| 2011-08-15 | 1430306 | TNXP | 10-Q | Url |
| 2011-05-04 | 1430306 | TNXP | 10-Q | Url |
| 2011-03-02 | 1430306 | TNXP | 10-K | Url |
| 2010-11-08 | 1430306 | TNXP | 10-Q | Url |
| 2010-08-09 | 1430306 | TNXP | 10-Q | Url |
| 2010-05-04 | 1430306 | TNXP | 10-Q | Url |
| 2010-02-16 | 1430306 | TNXP | 10-K | Url |
| 2009-11-05 | 1430306 | TNXP | 10-Q | Url |
| 2009-08-05 | 1430306 | TNXP | 10-Q | Url |
| 2009-05-12 | 1430306 | TNXP | 10-Q | Url |
| 2009-03-17 | 1430306 | TNXP | 10-K | Url |
| 2008-11-05 | 1430306 | TNXP | 10-Q | Url |
| 2008-08-14 | 1430306 | TNXP | 10-Q | Url |
| 2008-05-15 | 1430306 | TNXP | 10-Q | Url |
| 2008-04-09 | 1430306 | TNXP | S-1 | Url |
Tonix Pharmaceuticals(NASDAQ:TNXP) 
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases an...
Website: http://www.tonixpharma.com
Founded: 2007
IPO Price: $4.25 (Aug 09, 2013)
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about TNXP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.